Outcomes after Functional Nasal Surgery in Patients with Versus without Rhinitis Medicamentosa

Anthony P. Di Ponio,Mohammad‐Nadim Samad,Richard Pellizzari,Hussein Mackie,Robert H. Deeb,John R. Craig
DOI: https://doi.org/10.1002/lary.31839
IF: 2.97
2024-10-11
The Laryngoscope
Abstract:This retrospective case–control study assessed the long‐term surgical outcomes of rhinitis medicamentosa (RM) patients who underwent bilateral inferior turbinate reduction with or without septoplasty and nasal valve surgery, and compared their outcomes with patients without RM. No significant difference in Nasal Obstruction Symptom Evaluation (NOSE) score reductions at long‐term postoperative follow‐up was noted between the 36 RM patients and 116 patients with no history of RM. Additionally, long‐term topical nasal decongestant (TND) cessation was maintained in 86.1% of RM patients. Objective Topical nasal decongestants (TNDs) are used to reduce nasal soft tissue edema and obstruction. However, after frequent TND use, patients can develop rhinitis medicamentosa (RM) with rebound nasal edema and obstruction. Management of RM has centered largely on TND cessation ± intranasal corticosteroids. The purpose of this study was to compare nasal obstruction outcomes following nasal obstruction surgery in patients with versus without RM. Methods A retrospective case–control study was conducted with adult patients who underwent bilateral inferior turbinate reduction (ITR) with or without septoplasty and nasal valve repair. Patients with versus without RM were assessed. RM was defined as at least daily TND use for ≥4 weeks. Preoperative and postoperative Nasal Obstruction Symptom Evaluation (NOSE) scores, and long‐term TND cessation rates were collected. NOSE score changes were compared between patients with versus without RM. Results Of the 36 RM patients, mean age was 52.0 years, and 63.9% were male. Of 116 non‐RM patients, mean age was 41.6 years, and 46.6% were male. Postoperative NOSE scores were collected at a mean 972.1 days postoperatively for RM patients, and 565.0 days for non‐RM patients. Mean NOSE score reductions were − 9.8 for RM and − 8.6 for non‐RM patients, both of which were significant (p
medicine, research & experimental,otorhinolaryngology
What problem does this paper attempt to address?